557 related articles for article (PubMed ID: 11981733)
21. Yellow fever: the recurring plague.
Tomori O
Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
[TBL] [Abstract][Full Text] [Related]
22. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
Tomori O
Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
[TBL] [Abstract][Full Text] [Related]
23. The global burden of yellow fever.
Gaythorpe KA; Hamlet A; Jean K; Garkauskas Ramos D; Cibrelus L; Garske T; Ferguson N
Elife; 2021 Mar; 10():. PubMed ID: 33722340
[TBL] [Abstract][Full Text] [Related]
24. Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers.
Lown BA; Chen LH; Han PV; Jentes ES; Wilson ME; Benoit CM; Avery KA; Ooi W; Hamer DH; Barnett ED;
J Travel Med; 2014; 21(4):266-71. PubMed ID: 24734961
[TBL] [Abstract][Full Text] [Related]
25. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.
Farez MF; Correale J
Arch Neurol; 2011 Oct; 68(10):1267-71. PubMed ID: 21670384
[TBL] [Abstract][Full Text] [Related]
26. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-related transmission of yellow fever vaccine virus--California, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):34-7. PubMed ID: 20094025
[TBL] [Abstract][Full Text] [Related]
28. Yellow fever: an update.
Monath TP
Lancet Infect Dis; 2001 Aug; 1(1):11-20. PubMed ID: 11871403
[TBL] [Abstract][Full Text] [Related]
29. Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].
Martins RM; Galler R; Freire MS; Camacho LA; de Lourdes S Maia M; Homma A
Vaccine; 2007 Jan; 25(1):10-1. PubMed ID: 16448728
[TBL] [Abstract][Full Text] [Related]
30. Yellow fever vaccine.
Monath TP
Expert Rev Vaccines; 2005 Aug; 4(4):553-74. PubMed ID: 16117712
[TBL] [Abstract][Full Text] [Related]
31. [Yellow fever: new recommendations].
Rochat L; Genton B
Rev Med Suisse; 2014 May; 10(429):1014-9. PubMed ID: 24908746
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.
Belmusto-Worn VE; Sanchez JL; McCarthy K; Nichols R; Bautista CT; Magill AJ; Pastor-Cauna G; Echevarria C; Laguna-Torres VA; Samame BK; Baldeon ME; Burans JP; Olson JG; Bedford P; Kitchener S; Monath TP
Am J Trop Med Hyg; 2005 Feb; 72(2):189-97. PubMed ID: 15741556
[TBL] [Abstract][Full Text] [Related]
33. Yellow fever recommendations for tourists to Kenya: a flawed risk assessment.
Monath TP; Gershman M; Hill DR; Marano N; Staples JE; Wilder-Smith A
J Travel Med; 2009; 16(2):146; author reply 146-7. PubMed ID: 19335822
[No Abstract] [Full Text] [Related]
34. Yellow fever vaccination coverage among children in Brazilian capitals.
Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
[TBL] [Abstract][Full Text] [Related]
35. Yellow fever in a Brazilian family returning from vacation in an endemic area: relevant clinical features and epidemiological issues.
Chaves TS; Vasconcelos MJ; Filho NO; Alves JR
J Travel Med; 2009; 16(6):433-5. PubMed ID: 19930387
[TBL] [Abstract][Full Text] [Related]
36. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
Lopez-Velez R; Bayas JM
J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
[TBL] [Abstract][Full Text] [Related]
37. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
[TBL] [Abstract][Full Text] [Related]
38. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
Baba MM; Ikusemoran M
Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
[TBL] [Abstract][Full Text] [Related]
39. Yellow fever vaccine: an effective vaccine for travelers.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
[TBL] [Abstract][Full Text] [Related]
40. An inactivated cell-culture vaccine against yellow fever.
Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
